PNC Financial Services Group
ICPT

PNC Financial Services Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

PNC Financial Services Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18
Closed – – 4317
2021
Q1 		$0 Hold
18
– – ﹤0.01% 4242
2020
Q4 		$0 Sell
18
-446
-96% -$14.8K ﹤0.01% 4105
2020
Q3 		$19K Sell
464
-170
-27% -$7.81K ﹤0.01% 3266
2020
Q2 		$30K Sell
634
-156
-20% -$12.1K ﹤0.01% 3025
2020
Q1 		$49K Buy
790
+234
+42% +$21K ﹤0.01% 2649
2019
Q4 		$68K Sell
556
-8
-1% -$716 ﹤0.01% 2716
2019
Q3 		$36K Sell
564
-423
-43% -$28.4K ﹤0.01% 3095
2019
Q2 		$79K Buy
987
+49
+5% +$4.39K ﹤0.01% 2676
2019
Q1 		$105K Buy
938
+257
+38% +$28.1K ﹤0.01% 2522
2018
Q4 		$69K Sell
681
-14
-2% -$1.45K ﹤0.01% 2688
2018
Q3 		$89K Sell
695
-3
-0.4% -$317 ﹤0.01% 2662
2018
Q2 		$60K Sell
698
-239
-26% -$17.5K ﹤0.01% 2876
2018
Q1 		$57K Sell
937
-696
-43% -$41.9K ﹤0.01% 2885
2017
Q4 		$95K Buy
1,633
+322
+25% +$20.3K ﹤0.01% 2595
2017
Q3 		$76K Sell
1,311
-1,179
-47% -$127K ﹤0.01% 2684
2017
Q2 		$302K Buy
2,490
+470
+23% +$54.4K ﹤0.01% 1888
2017
Q1 		$229K Buy
2,020
+14
+0.7% +$1.63K ﹤0.01% 2061
2016
Q4 		$218K Buy
2,006
+1,806
+903% +$215K ﹤0.01% 2067
2016
Q3 		$32K Sell
200
-100
-33% -$15.8K ﹤0.01% 3032
2016
Q2 		$42K Buy
300
+200
+200% +$29.2K ﹤0.01% 2920
2016
Q1 		$12K Buy
100
+50
+100% +$5.9K ﹤0.01% 3508
2015
Q4 		$8K Sell
50
-50
-50% -$8.46K ﹤0.01% 3697
2015
Q3 		$16K Sell
100
-1,180
-92% -$260K ﹤0.01% 3483
2015
Q2 		$308K Buy
1,280
+930
+266% +$248K ﹤0.01% 1936
2015
Q1 		$98K Buy
350
+290
+483% +$62.8K ﹤0.01% 2697
2014
Q4 		$10K Sell
60
-63
-51% -$11.6K ﹤0.01% 3380
2014
Q3 		$29K Sell
123
-679
-85% -$173K ﹤0.01% 2919
2014
Q2 		$189K Buy
802
+275
+52% +$72.5K ﹤0.01% 1951
2014
Q1 		$174K Buy
+527
New +$178K ﹤0.01% 1957

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PNC Financial Services Group's ICPT Position: Q2 2021 in Review

PNC Financial Services Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 18 shares.

PNC Financial Services Group first reported a position in ICPT in Q1 2014 and held it in 29 quarters. The position peaked at $308K in Q2 2015. 130 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

  • PNC Financial Services Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 18 Intercept Pharmaceuticals, Inc. shares in Q2 2021.
  • PNC Financial Services Group first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 29 quarters.
  • PNC Financial Services Group's Intercept Pharmaceuticals, Inc. position peaked at $308K in Q2 2015.
  • 130 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on PNC Financial Services Group's 13F filing for Q2 2021, filed 6 Aug 2021.